Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease

Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) includes liver disease processes from simple fatty liver to nonalcoholic steatohepatitis, which may progress to liver fibrosis, cirrhosis, and even hepatocellular carcinoma (HCC). As the incidence of HCC derived from viral hepatitis de...

Full description

Saved in:
Bibliographic Details
Main Authors: Chenyang Mu, Sijie Wang, Zenghan Wang, Jian Tan, Haozan Yin, Yuefan Wang, Zhihui Dai, Dongyang Ding, Fu Yang
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Annals of Hepatology
Subjects:
Mitochondria
Metabolic dysfunction-associated steatotic liver disease
Mitochondrial dysfunction
Pathogenesis
Treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S166526812400557X
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items